We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · July 02, 2020

Perampanel as Adjunctive Therapy in Drug-Resistant Focal Epilepsy in a Real World Context

Journal of the Neurological Sciences

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the Neurological Sciences
The Efficacy of Perampanel as Adjunctive Therapy in Drug-Resistant Focal Epilepsy in a "Real World" Context: Focus on Temporal Lobe Epilepsy
J. Neurol. Sci. 2020 May 15;415(xx)116903, A Pascarella, LF Iannone, G Di Gennaro, A D'Aniello, E Ferlazzo, N Gagliostro, F Ursini, P Bonanni, N Paciello, A Romigi, U Aguglia, G De Sarro, E Russo, A Gambardella, A Labate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading